Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Reply: Assessing the Quality of Microvascular Breast Reconstruction Performed in the Urban Safety-Net Setting: A Doubly Robust Regression Analysis.

Offodile AC 2nd, Boukovalas S, Muldoon LD, Lee CN.

Plast Reconstr Surg. 2019 Nov;144(5):943e-944e. doi: 10.1097/PRS.0000000000006133. No abstract available.

PMID:
31688777
2.

Toll-like Receptor 4 Signaling and Downstream Neutrophilic Inflammation Mediate Endotoxemia-Enhanced Blood-Labyrinth Barrier Trafficking.

Urdang ZD, Bills JL, Cahana DY, Muldoon LL, Neuwelt EA.

Otol Neurotol. 2020 Jan;41(1):123-132. doi: 10.1097/MAO.0000000000002447.

PMID:
31568132
3.

Collecting Unused Medical Supplies in Emergency Departments for Responsible Redistribution.

Muldoon LB, Chan WW, Sabbagh SH, Rodriguez RM, Kanzaria HK.

J Emerg Med. 2019 Jul;57(1):29-35. doi: 10.1016/j.jemermed.2019.02.009. Epub 2019 Apr 25.

PMID:
31031071
4.

Assessing the Quality of Microvascular Breast Reconstruction Performed in the Urban Safety-Net Setting: A Doubly Robust Regression Analysis.

Offodile AC 2nd, Boukovalas S, Muldoon L, Lee CN.

Plast Reconstr Surg. 2019 Feb;143(2):361-370. doi: 10.1097/PRS.0000000000005191.

PMID:
30489498
5.

Stand basal area and solar radiation amplify white spruce climate sensitivity in interior Alaska: Evidence from carbon isotopes and tree rings.

Nicklen EF, Roland CA, Csank AZ, Wilmking M, Ruess RW, Muldoon LA.

Glob Chang Biol. 2019 Mar;25(3):911-926. doi: 10.1111/gcb.14511. Epub 2018 Dec 1.

PMID:
30408264
6.

Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.

Barajas RF, Hamilton BE, Schwartz D, McConnell HL, Pettersson DR, Horvath A, Szidonya L, Varallyay CG, Firkins J, Jaboin JJ, Kubicky CD, Raslan AM, Dogan A, Cetas JS, Ciporen J, Han SJ, Ambady P, Muldoon LL, Woltjer R, Rooney WD, Neuwelt EA.

Neuro Oncol. 2019 Mar 18;21(4):517-526. doi: 10.1093/neuonc/noy160.

PMID:
30277536
7.

Delivering primary health care as envisioned: A model of health and well-being guiding community-governed primary care organizations.

Rayner J, Muldoon L, Bayoumi I, McMurchy D, Mulligan K, Tharao W.

J Integr Care (Brighton). 2018;26(3):231-241. doi: 10.1108/JICA-02-2018-0014.

8.

Assessing Medicare's Approach To Covering New Drugs In Bundled Payments For Oncology.

Muldoon LD, Pelizzari PM, Lang KA, Vandigo J, Pyenson BS.

Health Aff (Millwood). 2018 May;37(5):743-750. doi: 10.1377/hlthaff.2017.1552.

PMID:
29733731
9.

Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.

Varallyay CG, Nesbit E, Horvath A, Varallyay P, Fu R, Gahramanov S, Muldoon LL, Li X, Rooney WD, Neuwelt EA.

J Magn Reson Imaging. 2018 Aug;48(2):441-448. doi: 10.1002/jmri.25943. Epub 2018 Jan 4.

10.

Cardiovascular preventive care for patients with serious mental illness.

Ritchie S, Muldoon L.

Can Fam Physician. 2017 Nov;63(11):e483-e487.

11.

The site of care matters: An examination of the relationship between high Medicaid burden hospitals and the use, cost, and complications of immediate breast reconstruction after mastectomy.

Offodile AC 2nd, Muldoon LD, Gani F, Canner JK, Jacobs LK.

Cancer. 2018 Jan 15;124(2):346-355. doi: 10.1002/cncr.31046. Epub 2017 Oct 17.

12.

Enhancing the cytotoxicity of chemoradiation with radiation-guided delivery of anti-MGMT morpholino oligonucleotides in non-methylated solid tumors.

Ambady P, Wu YJ, Walker JM, Kersch C, Pagel MA, Woltjer RL, Fu R, Muldoon LL, Neuwelt EA.

Cancer Gene Ther. 2017 Aug;24(8):348-357. doi: 10.1038/cgt.2017.27. Epub 2017 Jul 28.

13.

High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats.

Wu YJ, Pagel MA, Muldoon LL, Fu R, Neuwelt EA.

Anticancer Res. 2017 Aug;37(8):4029-4040.

14.

Staff perceptions of community health centre team function in Ontario.

Rayner J, Muldoon L.

Can Fam Physician. 2017 Jul;63(7):e335-e340.

15.

Design Challenges of an Episode-Based Payment Model in Oncology: The Centers for Medicare & Medicaid Services Oncology Care Model.

Kline RM, Muldoon LD, Schumacher HK, Strawbridge LM, York AW, Mortimer LK, Falb AF, Cox KJ, Bazell C, Lukens EW, Kapp MC, Rajkumar R, Bassano A, Conway PH.

J Oncol Pract. 2017 Jul;13(7):e632-e645. doi: 10.1200/JOP.2016.015834. Epub 2017 May 23.

16.

Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.

Toth GB, Varallyay CG, Horvath A, Bashir MR, Choyke PL, Daldrup-Link HE, Dosa E, Finn JP, Gahramanov S, Harisinghani M, Macdougall I, Neuwelt A, Vasanawala SS, Ambady P, Barajas R, Cetas JS, Ciporen J, DeLoughery TJ, Doolittle ND, Fu R, Grinstead J, Guimaraes AR, Hamilton BE, Li X, McConnell HL, Muldoon LL, Nesbit G, Netto JP, Petterson D, Rooney WD, Schwartz D, Szidonya L, Neuwelt EA.

Kidney Int. 2017 Jul;92(1):47-66. doi: 10.1016/j.kint.2016.12.037. Epub 2017 Apr 20. Review.

17.

Outwitting the Blood-Brain Barrier.

Neuwelt E, Ambady P, Muldoon L, McConnell H, Doolittle N.

Oncology (Williston Park). 2016 Nov 15;30(11):963, 966-7. No abstract available.

18.

Association Between Hospital Participation in a Medicare Bundled Payment Initiative and Payments and Quality Outcomes for Lower Extremity Joint Replacement Episodes.

Dummit LA, Kahvecioglu D, Marrufo G, Rajkumar R, Marshall J, Tan E, Press MJ, Flood S, Muldoon LD, Gu Q, Hassol A, Bott DM, Bassano A, Conway PH.

JAMA. 2016 Sep 27;316(12):1267-78. doi: 10.1001/jama.2016.12717.

PMID:
27653006
19.

Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific.

McConnell HL, Schwartz DL, Richardson BE, Woltjer RL, Muldoon LL, Neuwelt EA.

Nanomedicine. 2016 Aug;12(6):1535-42. doi: 10.1016/j.nano.2016.03.009. Epub 2016 Apr 9.

20.

Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.

Muldoon LL, Pagel MA, Netto JP, Neuwelt EA.

J Neurooncol. 2016 Feb;126(3):447-54. doi: 10.1007/s11060-015-2000-1. Epub 2015 Dec 2.

PMID:
26694547
21.

Dose-Dependent Neurotoxicity (Seizures) Due to Deposition of Gadolinium-based Contrast Agents in the Central Nervous System.

Muldoon LL, Neuwelt EA.

Radiology. 2015 Dec;277(3):925-6. doi: 10.1148/radiol.2015151028. No abstract available.

PMID:
26599933
22.

Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain.

Lal S, Kersch C, Beeson KA, Wu YJ, Muldoon LL, Neuwelt EA.

PLoS One. 2015 Jul 29;10(7):e0131842. doi: 10.1371/journal.pone.0131842. eCollection 2015.

23.
24.

Unsanctifying the sanctuary: challenges and opportunities with brain metastases.

Puhalla S, Elmquist W, Freyer D, Kleinberg L, Adkins C, Lockman P, McGregor J, Muldoon L, Nesbit G, Peereboom D, Smith Q, Walker S, Neuwelt E.

Neuro Oncol. 2015 May;17(5):639-51. doi: 10.1093/neuonc/nov023. Review.

25.

Roles of nurse practitioners and family physicians in community health centres.

Dahrouge S, Muldoon L, Ward N, Hogg W, Russell G, Taylor-Sussex R.

Can Fam Physician. 2014 Nov;60(11):1020-7.

26.

N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models.

Muldoon LL, Wu YJ, Pagel MA, Neuwelt EA.

J Neurooncol. 2015 Feb;121(3):433-40. doi: 10.1007/s11060-014-1657-1. Epub 2014 Nov 21.

27.

Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances.

Doolittle ND, Muldoon LL, Culp AY, Neuwelt EA.

Adv Pharmacol. 2014;71:203-43. doi: 10.1016/bs.apha.2014.06.002. Epub 2014 Aug 22. Review.

28.

Pandemic of great expectations.

Muldoon L.

Can Fam Physician. 2014 Sep;60(9):797. No abstract available.

29.

Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

Nasseri M, Gahramanov S, Netto JP, Fu R, Muldoon LL, Varallyay C, Hamilton BE, Neuwelt EA.

Neuro Oncol. 2014 Aug;16(8):1146-54. doi: 10.1093/neuonc/not328. Epub 2014 Feb 11.

30.

Patient-reported access to primary care in Ontario: effect of organizational characteristics.

Muggah E, Hogg W, Dahrouge S, Russell G, Kristjansson E, Muldoon L, Devlin RA.

Can Fam Physician. 2014 Jan;60(1):e24-31.

31.

Preservation of cognitive function in primary CNS lymphoma survivors a median of 12 years after enhanced chemotherapy delivery.

Doolittle ND, Dósa E, Fu R, Muldoon LL, Maron LM, Lubow MA, Tyson RM, Lacy CA, Kraemer DF, Butler RW, Neuwelt EA.

J Clin Oncol. 2013 Nov 1;31(31):4026-7. doi: 10.1200/JCO.2013.52.7747. Epub 2013 Oct 7. No abstract available.

32.

Poverty and universal health care.

Muldoon L.

Can Fam Physician. 2013 Jun;59(6):612. No abstract available.

33.

Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma.

Wu YJ, Neuwelt AJ, Muldoon LL, Neuwelt EA.

Anticancer Res. 2013 Jun;33(6):2391-400.

34.

Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.

Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, Fu R, Dósa E, Illerhaus G, Kraemer DF, Muldoon LL, Calabrese P, Hedrick N, Tyson RM, Jahnke K, Maron LM, Butler RW, Neuwelt EA.

Neurology. 2013 Jul 2;81(1):84-92. doi: 10.1212/WNL.0b013e318297eeba. Epub 2013 May 17.

35.

How many patients should a family physician have? Factors to consider in answering a deceptively simple question.

Muldoon L, Dahrouge S, Russell G, Hogg W, Ward N.

Healthc Policy. 2012 May;7(4):26-34.

36.

Inhibition of SUR1 decreases the vascular permeability of cerebral metastases.

Thompson EM, Pishko GL, Muldoon LL, Neuwelt EA.

Neoplasia. 2013 May;15(5):535-43.

37.

Patient poverty and workload in primary care: study of prescription drug benefit recipients in community health centres.

Muldoon L, Rayner J, Dahrouge S.

Can Fam Physician. 2013 Apr;59(4):384-90. Erratum in: Can Fam Physician. 2013 Jun;59(6):612.

38.

High-resolution steady-state cerebral blood volume maps in patients with central nervous system neoplasms using ferumoxytol, a superparamagnetic iron oxide nanoparticle.

Varallyay CG, Nesbit E, Fu R, Gahramanov S, Moloney B, Earl E, Muldoon LL, Li X, Rooney WD, Neuwelt EA.

J Cereb Blood Flow Metab. 2013 May;33(5):780-6. doi: 10.1038/jcbfm.2013.36. Epub 2013 Mar 13.

39.

Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.

Gahramanov S, Muldoon LL, Varallyay CG, Li X, Kraemer DF, Fu R, Hamilton BE, Rooney WD, Neuwelt EA.

Radiology. 2013 Mar;266(3):842-52. doi: 10.1148/radiol.12111472. Epub 2012 Nov 30.

40.

Immunologic privilege in the central nervous system and the blood-brain barrier.

Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR, Neuwelt EA.

J Cereb Blood Flow Metab. 2013 Jan;33(1):13-21. doi: 10.1038/jcbfm.2012.153. Epub 2012 Oct 17. Review.

41.

Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model.

Wu YJ, Muldoon LL, Gahramanov S, Kraemer DF, Marshall DJ, Neuwelt EA.

J Neurooncol. 2012 Oct;110(1):27-36. doi: 10.1007/s11060-012-0942-0. Epub 2012 Jul 29.

42.

Estimating patient demographic profiles from practice location.

Shortt M, Hogg W, Devlin RA, Russell G, Muldoon L.

Can Fam Physician. 2012 Apr;58(4):414-9.

43.

Impact of remuneration and organizational factors on completing preventive manoeuvres in primary care practices.

Dahrouge S, Hogg WE, Russell G, Tuna M, Geneau R, Muldoon LK, Kristjansson E, Fletcher J.

CMAJ. 2012 Feb 7;184(2):E135-43. doi: 10.1503/cmaj.110407. Epub 2011 Dec 5.

44.

Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.

Gahramanov S, Muldoon LL, Li X, Neuwelt EA.

Radiology. 2011 Dec;261(3):796-804. doi: 10.1148/radiol.11103503. Epub 2011 Sep 21.

45.

MRI using ferumoxytol improves the visualization of central nervous system vascular malformations.

Dósa E, Tuladhar S, Muldoon LL, Hamilton BE, Rooney WD, Neuwelt EA.

Stroke. 2011 Jun;42(6):1581-8. doi: 10.1161/STROKEAHA.110.607994. Epub 2011 Apr 14.

46.

Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma.

Muldoon LL, Lewin SJ, Dósa E, Kraemer DF, Pagel MA, Doolittle ND, Neuwelt EA.

Clin Cancer Res. 2011 Apr 15;17(8):2207-15. doi: 10.1158/1078-0432.CCR-10-2923. Epub 2011 Mar 8.

47.

Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.

Dósa E, Guillaume DJ, Haluska M, Lacy CA, Hamilton BE, Njus JM, Rooney WD, Kraemer DF, Muldoon LL, Neuwelt EA.

Neuro Oncol. 2011 Feb;13(2):251-60. doi: 10.1093/neuonc/noq172. Epub 2010 Dec 16.

48.

Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models.

Muldoon LL, Gahramanov S, Li X, Marshall DJ, Kraemer DF, Neuwelt EA.

Neuro Oncol. 2011 Jan;13(1):51-60. doi: 10.1093/neuonc/noq150. Epub 2010 Dec 1.

49.

Dynamic-contrast-enhanced-MRI with extravasating contrast reagent: rat cerebral glioma blood volume determination.

Li X, Rooney WD, Várallyay CG, Gahramanov S, Muldoon LL, Goodman JA, Tagge IJ, Selzer AH, Pike MM, Neuwelt EA, Springer CS Jr.

J Magn Reson. 2010 Oct;206(2):190-9. doi: 10.1016/j.jmr.2010.07.004. Epub 2010 Jul 31.

50.

Community orientation in primary care practices: Results from the Comparison of Models of Primary Health Care in Ontario Study.

Muldoon L, Dahrouge S, Hogg W, Geneau R, Russell G, Shortt M.

Can Fam Physician. 2010 Jul;56(7):676-83.

Supplemental Content

Loading ...
Support Center